Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

ZBIO

Zenas BioPharma, Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • ZBIOZenas BioPharma (USA), LLC
    0Calm

    A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    Signing up patientsPhase 3990 patientsMain results: Jun 2030

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

0 sales (0 not pre-planned) · 1 purchase

  • MOULDER LEON O JRChief Executive Officer · May 18, 2026Bought 60,000 sharesabout $1.0 million ·

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Other newsNews report (8-K)Nov 6, 2026
  • New shares being soldNew shares being sold (424B5)Nov 6, 2026
  • Quarterly reportQuarterly report (10-Q)Nov 5, 2026
  • Shared quarterly resultsNews report (8-K)Nov 5, 2026
  • Shared information with investorsNews report (8-K)Oct 13, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Quarterly reportQuarterly report (10-Q)
Aug 13, 2026
  • Shared quarterly results; An executive or board member joined or leftNews report (8-K)Aug 13, 2026
  • Quarterly reportQuarterly report (10-Q)May 13, 2026
  • Shared quarterly results; An executive or board member joined or leftNews report (8-K)May 13, 2026